EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Unveiling MLLT3: A Key Transcription Factor in ESCC Prognosis and Immune Infiltration

Shuolei Li, Yashu Zhang, Yongtao Bai

Molecular Carcinogenesis · 2026-11-17

DOI: 10.1002/mc.70208 ↗

At a glance

Journal article in Molecular Carcinogenesis, published online on 2026-11-17. Written by Shuolei Li and 2 co-authors. 40 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The transcription factor Myeloid/lymphoid or mixed‐lineage leukemia; translocated to, 3 (MLLT3) super elongation complex subunit plays an important role in the regulation of oncogenes and suppressor genes during cancer progression; however, how they participate in the occurrence and development of esophageal squamous cell carcinoma (ESCC) has yet to be fully elucidated. Using Genotype‐Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA), differential expression analysis of 1,834 transcription factors (TFs) was performed, which identified 251 up‐regulated and 159 down‐regulated TFs. Enrichment analysis revealed that differentially expressed TFs (DETFs) were implicated in the transcriptional misregulation of cancer. A total of 17 candidate DETFs were associated with survival. Subsequently, transcription factor like 5 (TCFL5), MLLT3, zinc finger family (ZNF) 274, and ZNF 697 were identified as four key genes associated with disease progression by least absolute shrinkage and selection operator and random forest algorithms. In univariable Cox regression with hazard ratios expressed per 1 standard deviation (SD) of expression, MLLT3 [HR = 0.430, 95% confidence interval (CI): 0.267‐0.693, P = 5.2 × 10 −4 ; Benjamini‐Hochberg adjusted p = 0.009] was the transcription factor most strongly associated with overall survival. Single‐cell transcriptome data showed that MLLT3 was exceptionally expressed in T cell subpopulations. Pan‐cancer analysis revealed that MLLT3 exhibited significant positive correlations with CD4 + resting memory T cells across 14 cancer types. Notably, in esophageal carcinoma (ESCA), MLLT3 expression showed a moderately strong positive correlation with CD4 + resting memory T cell infiltration (Spearman rho = 0.452, P = 1.91 × 10 −10 ), suggesting a potential association. Reduced MLLT3 expression was detected in ESCC, suggesting its potential tumor‐suppressor role. In vitro experiments demonstrated that MLLT3 knockdown significantly promoted cancer cell proliferation and migration. Mechanistically, MLLT3 may modulate the levels of phosphorylated extracellular signal‐regulated kinase, a key effector in the mitogen‐activated protein kinase signaling pathway, thereby mediating its anti‐tumor effects. These findings indicate that MLLT3 acts as a tumor suppressor gene, providing novel insights into its dual role in shaping immune infiltration and disease progression.

Cite

APA

Li, S., Zhang, Y., & Bai, Y. (2026). Unveiling MLLT3: A Key Transcription Factor in ESCC Prognosis and Immune Infiltration. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70208

Vancouver

Li S, Zhang Y, Bai Y. Unveiling MLLT3: A Key Transcription Factor in ESCC Prognosis and Immune Infiltration. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70208

BibTeX
@article{Li2026,
  author = {Li, Shuolei and Zhang, Yashu and Bai, Yongtao},
  title = {Unveiling MLLT3: A Key Transcription Factor in ESCC Prognosis and Immune Infiltration},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  doi = {10.1002/mc.70208}
}
Start for free →